AMI
Clinical trials for AMI explained in plain language.
Never miss a new study
Get alerted when new AMI trials appear
Sign up with your email to follow new studies for AMI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to limit heart damage after major attack
Disease control Recruiting nowThis study tests a medicine called Xolatryp in adults who have had a severe heart attack (STEMI) and are getting a procedure to open blocked arteries. Participants receive either a single 6-hour infusion of Xolatryp or a placebo, and their heart health is monitored for 30 days. T…
Matched conditions: AMI
Phase: PHASE2 • Sponsor: Nyrada Pty Ltd • Aim: Disease control
Last updated Jul 02, 2026 02:00 UTC
-
New oxygen therapy may limit heart damage after attack
Disease control Recruiting nowThis study tracks 1,000 heart attack patients to see if adding SuperSaturated Oxygen therapy to standard angioplasty reduces heart muscle damage and improves outcomes. Participants are adults aged 18-80 who had a specific type of heart attack. The goal is to learn if this extra t…
Matched conditions: AMI
Sponsor: TherOx • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could a common diabetes pill prevent heart failure after a heart attack?
Disease control Recruiting nowThis study tests whether dapagliflozin, a drug already used for diabetes and heart failure, can help the heart heal better after a heart attack. About 450 adults who have had a heart attack and have weak heart pumping will receive either the drug or a placebo for 6 months. The go…
Matched conditions: AMI
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC